Abstract
Objective: Type 2 diabetes with obesity is regarded as an incurable, progressive disease with many complications. The hypothesis was tested that glycated haemoglobin (HbA1c) and the insulin release curve can be restored by traceable systematic methods. Methods: 122 people with diabesity were investigated before and after three and 6 months of traceable systematic management methods. Basal body mass index (BMI), fatty liver, HbA1c, and insulin release curve were measured. Results: After 3 months of traceable systematic management, BMI decreased from 30.76 ± 0.48 to 21.86 ± 0.09 kg/m2 (p < 0.001) and remained stable during the last 3 months (21.82 ± 0.09 kg/m2 at 6 months). Colour Doppler ultrasound showed non-alcoholic fatty liver disease (NAFLD) in all diabesity participants at baseline. At 3 months, only one participant had low-grade fatty liver, and fatty liver was reversed in other participants (p < 0.001). The number and grade of fatty liver at 6 months were the same as at 3 months. Fasting plasma glucose decreased and continued to decrease thereafter (p < 0.001). Two-hour postprandial plasma glucose decreased and continued to decline until 6 months (p < 0.001). HbA1c also decreased and maintained this level at 6 months. At baseline, the peak value of insulin release was 1,141.09 ± 43.02 pmol/L at 2 h after meals, and the early phase of insulin secretion was lost. After 3 months of management, the insulin concentration was 621.62 ± 19.32 pmol/L at 2 h after meals. After 6 months, the value decreased, and the early phase of insulin secretion recovered. Conclusions: Normalization of the insulin release curve in type 2 diabetes was achieved by traceable systematic methods. This was associated with recovery from NAFLD. Diabesity is reversible by traceable systematic management.
References
1.
Pappachan
JM
, Viswanath
AK
. Medical management of diabesity: do we have realistic targets?
Curr Diab Rep
. 2017
;17
(1
):4
. .2.
DeFronzo
RA
, Ferrannini
E
, Groop
L
, Henry
RR
, Herman
WH
, Holst
JJ
, Type 2 diabetes mellitus
. Nat Rev Dis Primers
. 2015
;1
:15019
. .3.
Seino
S
, Shibasaki
T
, Minami
K
. Dynamics of insulin secretion and the clinical implications for obesity and diabetes
. J Clin Invest
. 2011
;121
(6
):2118
–25
. .4.
Lim
EL
, Hollingsworth
KG
, Aribisala
BS
, Chen
MJ
, Mathers
JC
, Taylor
R
, Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol
. Diabetologia
. 2011
;54
(10
):2506
–14
. .5.
Zhyzhneuskaya
SV
, Al-Mrabeh
A
, Peters
C
, Barnes
A
, Aribisala
B
, Hollingsworth
KG
, Time course of normalization of functional beta-cell capacity in the diabetes remission clinical trial after weight loss in type 2 diabetes
. Diabetes Care
. 2020
;43
(4
):813
–20
. .6.
Al-Mrabeh
A
, Hollingsworth
KG
, Shaw
JAM
, McConnachie
A
, Sattar
N
, Lean
MEJ
, 2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial
. Lancet Diabetes Endocrinol
. 2020
;8
(12
):939
–48
. .7.
Camastra
S
, Muscelli
E
, Gastaldelli
A
, Holst
JJ
, Astiarraga
B
, Baldi
S
, Long-term effects of bariatric surgery on meal disposal and beta-cell function in diabetic and nondiabetic patients
. Diabetes
. 2013
;62
(11
):3709
–17
. .8.
Kashyap
SR
, Daud
S
, Kelly
KR
, Gastaldelli
A
, Win
H
, Brethauer
S
, Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes
. Int J Obes
. 2010
;34
(3
):462
–71
. .9.
Kashyap
SR
, Bhatt
DL
, Wolski
K
, Watanabe
RM
, Abdul-Ghani
M
, Abood
B
, Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment
. Diabetes Care
. 2013
;36
(8
):2175
–82
. .10.
Hallberg
SJ
, Gershuni
VM
, Hazbun
TL
, Athinarayanan
SJ
. Reversing type 2 diabetes: a narrative review of the evidence
. Nutrients
. 2019
;11
(4
):766
. .11.
Lean
ME
, Leslie
WS
, Barnes
AC
, Brosnahan
N
, Thom
G
, McCombie
L
, Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
. Lancet
. 2018
;391
(10120
):541
–51
. .12.
Lean
MEJ
, Leslie
WS
, Barnes
AC
, Brosnahan
N
, Thom
G
, McCombie
L
, Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
. Lancet Diabetes Endocrinol
. 2019
;7
(5
):344
–55
. .13.
Byrne
CD
, Targher
G
, Targher
G
. NAFLD: a multisystem disease
. J Hepatol
. 2015
;62
(1
):S47
–64
. .14.
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
. Report of the expert committee on the diagnosis and classification of diabetes mellitus
. Diabetes Care
. 1997
;20
(7
):1183
–97
. .15.
Hou
X
, Lu
J
, Weng
J
, Ji
L
, Shan
Z
, Liu
J
, Impact of waist circumference and body mass index on risk of cardiometabolic disorder and cardiovascular disease in Chinese adults: a national diabetes and metabolic disorders survey
. PLoS One
. 2013
;8
(3
):e57319
. .16.
Wong
VWS
, Chan
WK
, Chitturi
S
, Chawla
Y
, Dan
YY
, Duseja
A
, Asia-pacific working party on non-alcoholic fatty liver disease guidelines 2017-Part 1: definition, risk factors and assessment
. J Gastroenterol Hepatol
. 2018
;33
(1
):70
–85
. .17.
ACSM
. ACSMs guidelines for exercise testing and prescrip-tion
. Philadelphia
: Lippincott Williams & Wilkins
; 2010
.18.
Riddle
MC
, Cefalu
WT
, Evans
PH
, Gerstein
HC
, Nauck
MA
, Oh
WK
, Consensus report: definition and interpretation of remission in type 2 diabetes
. Diabetologia
. 2021
;64
(11
):2359
–66
. .19.
Samson
SL
, Garber
AJ
. Metabolic syndrome
. Endocrinol Metab Clin North Am
. 2014
;43
(1
):1
–23
. .20.
Schauer
PR
, Hanipah
ZN
, Rubino
F
. Metabolic surgery for treating type 2 diabetes mellitus: now supported by the world's leading diabetes organizations
. Cleve Clin J Med
. 2017
;84
(7 Suppl 1
):S47
–56
. .21.
Rubino
F
, Gagner
M
. Potential of surgery for curing type 2 diabetes mellitus
. Ann Surg
. 2002
;236
(5
):554
–9
. .22.
Cohen
R
, Caravatto
PP
, Correa
JL
, Noujaim
P
, Petry
TZ
, Salles
JE
, Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index
. Surg Obes Relat Dis
. 2012
;8
(4
):375
–80
. .23.
Pories
WJ
, Mehaffey
JH
, Staton
KM
. The surgical treatment of type two diabetes mellitus
. Surg Clin North Am
. 2011
;91
(4
):821
–36
. viii .24.
Purnell
JQ
, Selzer
F
, Wahed
AS
, Pender
J
, Pories
W
, Pomp
A
, Type 2 diabetes remission rates after laparoscopic gastric bypass and gastric banding: results of the longitudinal assessment of bariatric surgery study
. Diabetes Care
. 2016
;39
(7
):1101
–7
. .25.
Velapati
SR
, Shah
M
, Kuchkuntla
AR
, Abu-Dayyeh
B
, Grothe
K
, Hurt
RT
, Weight regain after bariatric surgery: prevalence, etiology, and treatment
. Curr Nutr Rep
. 2018
;7
(4
):329
–34
. .26.
Shoar
S
, Nguyen
T
, Ona
MA
, Reddy
M
, Anand
S
, Alkuwari
MJ
, Roux-en-Y gastric bypass reversal: a systematic review
. Surg Obes Relat Dis
. 2016
;12
(7
):1366
–72
. .27.
Bistrian
BR
, Blackburn
GL
, Flatt
JP
, Sizer
J
, Scrimshaw
NS
, Sherman
M
, Nitrogen metabolism and insulin requirements in obese diabetic adults on a protein-sparing modified fast
. Diabetes
. 1976
;25
(6
):494
–504
. .28.
Ryan
DH
, Espeland
MA
, Foster
GD
, Haffner
SM
, Hubbard
VS
, Johnson
KC
, Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes
. Control Clin Trials
. 2003
;24
(5
):610
–28
. .29.
Campbell
WR
. Dietetic treatment in diabetes mellitus
. Can Med Assoc J
. 1923
;13
(7
):487
–92
.30.
Westman
EC
, Feinman
RD
, Mavropoulos
JC
, Vernon
MC
, Volek
JS
, Wortman
JA
, Low-carbohydrate nutrition and metabolism
. Am J Clin Nutr
. 2007
;86
(2
):276
–84
. .31.
Daly
ME
, Paisey
R
, Paisey
R
, Millward
BA
, Eccles
C
, Williams
K
, Short-term effects of severe dietary carbohydrate-restriction advice in type 2 diabetes: a randomized controlled trial
. Diabet Med
. 2006
;23
(1
):15
–20
. .32.
Hussain
TA
, Mathew
TC
, Dashti
AA
, Asfar
S
, Al-Zaid
N
, Dashti
HM
, Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes
. Nutrition
. 2012
;28
(10
):1016
–21
. .33.
Gardner
CD
, Kim
S
, Bersamin
A
, Dopler-Nelson
M
, Otten
J
, Oelrich
B
, Micronutrient quality of weight-loss diets that focus on macronutrients: results from the A TO Z study
. Am J Clin Nutr
. 2010
;92
(2
):304
–12
. .34.
Dashti
HM
, Mathew
TC
, Al-Zaid
NS
. Efficacy of low-carbohydrate ketogenic diet in the treatment of type 2 diabetes
. Med Princ Pract
. 2021
;30
(3
):223
–35
. .35.
Gong
Q
, Zhang
P
, Wang
J
, An
Y
, Gregg
EW
, Li
H
, Changes in mortality in people with IGT before and after the onset of diabetes during the 23-year follow-up of the da qing diabetes prevention study
. Diabetes Care
. 2016
;39
(9
):1550
–5
. .36.
Look AHEAD Research Group
; Jakicic
J
, Clark
J
, Bloomquist
P
, Curtis
J
, Evans
M
, Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
. Lancet Diabetes Endocrinol
. 2016
;4
(11
):913
–21
. .37.
Xu
G
, Huang
X
, Lang
J
, Chen
W
. Summary of traceable systematic eradication of diabetes method
. In: Xu
G
, editor. Farewell to obesity and diabetes
. Hongkong
: China Erudite Press
; 2016
. p. 106
.38.
Xu
G
, Huang
X
, Lang
J
, Chen
W
. A new study on the pathophysiological mechanism of diabetes
. In: Xu
G
, editor. Farewell to obesity and diabetes
. Hongkong
: China Erudite Press
; 2016
. p. 76
.39.
Xu
G
, Huang
X
, Lang
J
, Chen
W
. A new study on the pathophysiological mechanism of diabetes
. In: Xu
G
, editor. Farewell to obesity and diabetes
. Hongkong
: China Erudite Press
; 2016
. p. 80
–1
.40.
Xu
G
, Huang
X
, Lang
J
, Chen
W
. A new study on the pathophysiological mechanism of diabetes
. In: Xu
G
, editor. Farewell to obesity and diabetes
. Hongkong
: China Erudite Press
; 2016
. p. 85
.41.
Al-Mrabeh
A
, Zhyzhneuskaya
SV
, Peters
C
, Barnes
AC
, Melhem
S
, Jesuthasan
A
, Hepatic lipoprotein export and remission of human type 2 diabetes after weight loss
. Cell Metab
. 2020
;31
(2
):233
–249.e4
.42.
Taylor
R
. Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause
. Diabetologia
. 2008
;51
(10
):1781
–9
. .43.
Samuel
V
, Shulman
G
. Mechanisms for insulin resistance: common threads and missing links
. Cell
. 2012 Mar 2
;148
(5
):852
–71
. .44.
Scheen
AJ
. Pathophysiology of type 2 diabetes
. Acta Clinica Belgica
. 2003
;58
(6
):335
–41
. .45.
Ozturk
A
, Grajo
JR
, Gee
MS
, Benjamin
A
, Zubajlo
RE
, Thomenius
KE
, Quantitative hepatic fat quantification in non-alcoholic fatty liver disease using ultrasound-based techniques: a review of literature and their diagnostic performance
. Ultrasound Med Biol
. 2018
;44
(12
):2461
–75
. .© 2022 S. Karger AG, Basel
2022
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
